Phase II randomised trial of first-line lenalidomide administered before or after conventional chemotherapy in patients with acute myeloid leukaemia.
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2013
At a glance
- Drugs Lenalidomide (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 05 Feb 2013 New trial record